2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-4-methyl-1H-imidazole-5-carboxylic acid

Catalog No. :
ACDUSE962
CAS No. :
2174007-71-5
Molecular Formula :
C25H25N3O4
Molecular Weight :
431.49

IUPAC Name:2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-4-methyl-1H-imidazole-5-carboxylic acid

2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-4-methyl-1H-imidazole-5-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-4-methyl-1H-imidazole-5-carboxylic acid
IUPAC Name2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-4-methyl-1H-imidazole-5-carboxylic acid
Molecular FormulaC25H25N3O4
Molecular Weight431.49
SMILESCC1=C(C(=O)O)NC(C2CCN(C(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)CC2)=N1
InChI KeyUTWXTCXQLIVGJS-UHFFFAOYSA-N
Synonym2-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-4-methyl-1H-imidazole-5-carboxylic acid;1-Piperidinecarboxylic acid, 4-(5-carboxy-4-methyl-1H-imidazol-2-yl)-, 1-(9H-fluoren-9-ylmethyl) ester
CAS No.2174007-71-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACDUSE962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDUSE962 route product structure diagram
    ACDUSE9622174007-71-5
Inquiry

2. ACDUSE962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDUSE962 route product structure diagram
    ACDUSE9622174007-71-5
Inquiry

Comments (0)